NCT06364982

Brief Summary

The aim of this study is to analyse contiguous dental implants and its peri-implant status depending on different inter-implant distances.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

April 5, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 15, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

July 17, 2024

Status Verified

July 1, 2024

Enrollment Period

9 months

First QC Date

January 31, 2024

Last Update Submit

July 16, 2024

Conditions

Keywords

Peri-implantitisPeri-implant diseasesPeri-implant mucositisInter-implant distances

Outcome Measures

Primary Outcomes (1)

  • Prevalence of peri-implant diseases.

    Prevalence of peri-implant mucositis and peri-implantitis.

    At least 36 months of function - at the moment of the evaluation

Secondary Outcomes (21)

  • FMPI

    At least 36 months of function - at the moment of the evaluation

  • FMBI

    At least 36 months of function - at the moment of the evaluation

  • mPI

    At least 36 months of function - at the moment of the evaluation

  • mBI

    At least 36 months of function - at the moment of the evaluation

  • SoP

    At least 36 months of function - at the moment of the evaluation

  • +16 more secondary outcomes

Study Arms (2)

Inter-implant distance ≤ 3mm

Presence of an inter-implant distance ≤ 3mm

Diagnostic Test: Two contiguous dental implants placed with less ≤ 3mm from each other.

Inter-implant distance ≥ 3mm

Presence of an inter-implant distance ≥ 3mm

Diagnostic Test: Two contiguous dental implants placed with > 3mm from each other.

Interventions

Implant Placement of 2 contiguous dental implants with less ≤ 3mm from each other.

Inter-implant distance ≤ 3mm

Implant Placement of 2 contiguous dental implants with \> 3mm from each other.

Inter-implant distance ≥ 3mm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects will be selected from an electronic database collected at the CUO (UIC) / CU (FMDUL) and composed of patients treated with at least two contiguous dental implants before 2021. This investigation will use a stratified random sampling based on year of implant placement to select a representative sample of subjects with implant-supported restorations conducted during the period 2001-2020 at the CUO and CU. Then, two examiners (I.T. / F.F.) will contact patients by telephone once every 2 days (with a maximum of 3 attempts) for an evaluation by the same investigators (I.T / F.F).

You may qualify if:

  • The patient must be ≥18 years of age and systemically healthy;
  • Partially edentulous patients, rehabilitated until 2020 (i.e., a minimum of 3 years of function time) with at least two contiguous implant-supported restorations in the maxilla or mandible;
  • Screw or cemented-retained prosthesis;
  • Fixed dental prosthesis (i.e., single crowns and partial prosthesis);
  • No implant mobility.

You may not qualify if:

  • Pregnant and lactating women;
  • Patients who have taken systemic antibiotics during the 3 months prior to the examination;
  • Patients being treated with drugs that may induce a gingival overgrowth;
  • Patients undergoing orthodontic treatment (since it can influence periodontal diagnosis);
  • Patients who have received mechanical debridement during the 3 months prior to the exam;
  • Patients who have received surgical treatment for peri-implantitis;
  • Psychophysical inability to carry out study procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clínica Universitaria de Odontologia

Sant Cugat del Vallès, Barcelona, 08195, Spain

RECRUITING

MeSH Terms

Conditions

Peri-Implantitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Cristina V Vallès, PhD

    Department of Periodontology, University Internacional de Cataluña

    STUDY DIRECTOR

Central Study Contacts

Ioannis Terpou, MSc

CONTACT

Tiago R Amaral, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD candidate

Study Record Dates

First Submitted

January 31, 2024

First Posted

April 15, 2024

Study Start

April 5, 2024

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

July 17, 2024

Record last verified: 2024-07

Locations